Osteoprotegerin and fractures in men and women with chronic kidney disease

Journal of Bone and Mineral Metabolism

Volumn 32, Issue 4, 2014, Pages 428-433

  West, Sarah L ^a,b   Lok, Charmaine E ^b,c   Jamal, Sophie A ^a,b  

^a WOMEN S COLLEGE HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Biomarker; Chronic kidney disease; Cytokine; Fractures; Osteoprotegerin

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; OSTEOPROTEGERIN; PARATHYROID HORMONE; PHOSPHATE;

ADULT; AGE DISTRIBUTION; ARM FRACTURE; ARTICLE; CALCIUM BLOOD LEVEL; CERVICAL SPINE FRACTURE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; ELBOW FRACTURE; FEMALE; FRACTURE; HAND FRACTURE; HIP FRACTURE; HUMAN; KIDNEY FUNCTION; KNEE FRACTURE; LEG FRACTURE; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PELVIS FRACTURE; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RIB FRACTURE; RISK ASSESSMENT; SELF REPORT; SHOULDER FRACTURE; SPINE FRACTURE; SPINE RADIOGRAPHY; VITAMIN BLOOD LEVEL; WRIST FRACTURE; AGED; BLOOD; CHRONIC KIDNEY FAILURE; MIDDLE AGED;

AGED; CALCIUM; FEMALE; FRACTURES, BONE; HUMANS; MALE; MIDDLE AGED; OSTEOPROTEGERIN; PARATHYROID HORMONE; PHOSPHATES; RENAL INSUFFICIENCY, CHRONIC;

EID: 84904561407     PISSN: 09148779     EISSN: 14355604     Source Type: Journal    
DOI: 10.1007/s00774-013-0506-1     Document Type: Article

References (29)

1. Nickolas TL, McMahon DJ, Shane E (2006) Relationship between moderate to severe kidney disease and hip fracture in the United States. J Am Soc Nephrol 17:3223-3232 (Pubitemid 44707784)
2. Coco M, Rush H (2000) Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. Am J Kidney Dis 36:1115-1121
3. Kazama JJ, Shigematsu T, Yano K, Tsuda E, Miura M, Iwasaki Y, Kawaguchi Y, Gejyo F, Kurokawa K, Fukagawa M (2002) Increased circulating levels of osteoclastogenesis inhibitory factor (osteoprotegerin) in patients with chronic renal failure. Am J Kidney Dis 39:525-532 (Pubitemid 34194628)
4. Styrkarsdottir U, Halldorsson BV, Gretarsdottir S, Gudbjartsson DF, Walters GB, Ingvarsson T, Jonsdottir T, Saemundsdottir J, Center JR, Nguyen TV, Bagger Y, Gulcher JR, Eisman JA, Christiansen C, Sigurdsson G, Kong A, Thorsteinsdottir U, Stefansson K (2008) Multiple genetic loci for bone mineral density and fractures. New Eng J Med 358:2355-2365 (Pubitemid 351749159)
5. Sypniewska G, Sobanska I, Pater A, Kedziora-Kornatowska K, Nowacki W (2010) Does serum osteoprotegerin level relate to fragility fracture in elderly women with low vitamin D status? Med Sci Monitor Int Med J Exp Clin Res 16:CR96-CR101
6. West SL, Lok CE, Jamal SA (2010) Fracture risk assessment in chronic kidney disease, prospective testing under real world environments (FRACTURE): a prospective study. BMC Nephrol 11:17. doi:10.1186/1471-2369-11-17
7. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation: Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461-470 (Pubitemid 29135798)
8. National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39:S1-S266
9. Jamal SA, Gilbert J, Gordon C, Bauer DC (2006) Cortical PQCT measures are associated with fractures in dialysis patients. J Bone Miner Res 21:543-548
10. World Health Organization (1994) Assessment of osteoporotic fracture risk and its role in screening for postmenopausal osteoporosis. WHO Technical Series Geneva
11. Black DM, Palermo L, Nevitt MC, Genant HK, Christensen L, Cummings SR (1999) Defining incident vertebral deformity: a prospective comparison of several approaches: The Study of Osteoporotic Fractures Research Group. J Bone Miner Res 14:90-101 (Pubitemid 29021608)
12. Kudlacek S, Schneider B, Woloszczuk W, Pietschmann P, Willvonsedera R (2003) Serum levels of osteoprotegerin increase with age in a healthy adult population. Bone 32:681
13. Doumouchtsis KK, Kostakis AI, Doumouchtsis SK, Tziamalis MP, Stathakis CP, Diamanti-Kandarakis E, Dimitroulis D, Perrea DN (2008) Associations between osteoprotegerin and femoral neck BMD in hemodialysis patients. J Bone Miner Metab 26:66-72 (Pubitemid 350307998)
14. Shimizu M, Onoe Y, Mikumo M, Miyabara Y, Kuroda T, Yoshikata R, Ishitani K, Okano H, Ohta H (2009) Variations in circulating osteoprotegerin and soluble RANKL during diurnal and menstrual cycles in young women. Horm Res 71:285-289. doi:10.1159/000208802
15. Dovio A, Generali D, Tampellini M, Berruti A, Tedoldi S, Torta M, Bonardi S, Tucci M, Allevi G, Aguggini S, Bottini A, Dogliotti L, Angeli A (2008) Variations along the 24-hour cycle of circulating osteoprotegerin and soluble RANKL: a rhythmometric analysis. Osteoporos Int 19:113-117. doi:10.1007/s00198- 007-0423-z (Pubitemid 350198054)
16. Moe S (2008) For the Working Group of the Kidney Disease Improving Global Outcome. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease related mineral and bone disorders (CKD-MBD). Clin J Am Soc Nephrol 3:5124-5130
17. Crisafulli A, Romeo A, Floccari F, Aloisi E, Atteritano M, Cincotta M, Aloisi C, Pizzoleo MA, Ruello A, Artemisia A, Valenti A, Frisina N, Teti D, Buemi M (2005) Osteoprotegerin and bone mineral density in hemodiafiltration patients. Ren Fail 27:531-539 (Pubitemid 41216308)
18. Wagner D, Fahrleitner-Pammer A (2010) Levels of osteoprotegerin (OPG) and receptor activator for nuclear factor kappa B ligand (RANKL) in serum: are they of any help? Wien Med Wochenschr 160:452-457. doi:10.1007/s10354-010-0818-x
19. Kazama JJ (2004) Osteoprotegerin and bone mineral metabolism in renal failure. Curr Opin Nephrol Hypertens 13:411-415
20. Cauley JA, Lui LY, Genant HK, Salamone L, Browner W, Fink HA, Cohen P, Hillier T, Bauer DC, Cummings SR (2009) Risk factors for severity and type of the hip fracture. J Bone Miner Res 24:943-955. doi:10.1359/jbmr.081246
21. Taylor BC, Schreiner PJ, Stone KL, Fink HA, Cummings SR, Nevitt MC, Bowman PJ, Ensrud KE (2004) Long-term prediction of incident hip fracture risk in elderly white women: study of osteoporotic fractures. J Am Geriatr Soc 52:1479-1486. doi:10.1111/j.1532-5415.2004.52410.x (Pubitemid 39209595)
22. Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet 359:1761-1767
23. National Kidney Foundation (2003) KDOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. Am J Kidney Dis 42:S1-S202
24. Oh ES, Rhee EJ, Oh KW, Lee WY, Baek KH, Yoon KH, Kang MI, Yun EJ, Park CY, Choi MG, Yoo HJ, Park SW (2005) Circulating osteoprotegerin levels are associated with age, waist-to- hip ratio, serum total cholesterol, and low-density lipoprotein cholesterol levels in healthy Korean women. Metabolism 54:49-54 (Pubitemid 39572456)
25. Fahrleitner-Pammer A, Dobnig H, Piswanger-Soelkner C, Bonelli C, Dimai HP, Leb G, Obermayer-Pietsch B (2003) Osteoprotegerin serum levels in women: correlation with age, bone mass, bone turnover and fracture status. Wien Klin Wochenschr 115:291-297 (Pubitemid 36753026)
26. Nickolas TL, Leonard MB, Shane E (2008) Chronic kidney disease and bone fracture: a growing concern. Kidney Int 74:721-731
27. Lewiecki EM, Miller PD (2013) Skeletal effects of primary hyperparathyroidism: bone mineral density and fracture risk. J Clin Densitom 16:28-32. doi:10.1016/j.jocd.2012.11.013
28. Doumouchtsis K, Perrea D, Doumouchtsis S, Tziamalis M, Poulakou M, Vlachos I, Kostakis A (2009) Regulatory effect of parathyroid hormone on sRANKL-osteoprotegerin in hemodialysis patients with renal bone disease. Therap Apheresis Dialysis 13:49-55
29. Findlay D, Chehade M, Tsangari H, Neale S, Hay S, Hopwood B, Pannach S, O'Loughlin P, Fazzalari N (2008) Circulating RANKL is inversely related to RANKL mRNA levels in bone in osteoarthritic males. Arthritis Res Ther 10:R2. doi:10.1186/ar2348